510(k) device
Noveos Immunoanalyzer System
Hycor Biomedical · System, Test, Radioallergosorbent (Rast) Immunological (DHB, Class II) · First FDA decision Jul 31, 2019, newest Feb 18, 2022Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Noveos Immunoanalyzer"
MAUDE reports
0
Brand "Noveos Immunoanalyzer", since 2015
PubMed studies
0
Mentioning "Noveos Immunoanalyzer"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Noveos Immunoanalyzer System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K220162 · Decided Feb 18, 2022 · 29 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
K191510 · Decided Jul 31, 2019 · 55 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Noveos Immunoanalyzer", any status and sponsor, newest update first.
No registered device study names "Noveos Immunoanalyzer".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Noveos Immunoanalyzer", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DHB
55 reports: 51 malfunction, 4 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Noveos Immunoanalyzer"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DHB.
- NOVEOS Specific IgE (sIgE)Hycor Biomedical · 510(k) 2026
- Immulite 2000 3GALLERGY Specific Ige Assay KitSiemens Healthcare Diagnostics, Inc. · 510(k) 2012
- ImmunoCAP Specific IgEPhadia AB · 510(k) 2018
- ImmunoCAP Allergen d202, Allergen component rDer p 1,House dust mitePhadia AB · 510(k) 2016
- Immulite 2000 3GALLERGY Specific Ige Assay Kit, Model L2KUN6Siemens Medical Solutions Diagnostics · 510(k) 2011
- Immulite 2000 Allergen-Specific IgeDiagnostic Products Corp. · 510(k) 2002
- IMMULITE 2000 3gAllergy Specific IgE VantageSiemens Healthcare Diagnostics Products, Ltd. · 510(k) 2026
- ImmunoCAP Allergen f433Phadia AB · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.